Volume 5, Issue 2
Review Articlep. 159
Long-term outcome of pulmonary embolism
Author(s): Guy Meyer, Benjamin Planquette and Olivier Sanchez
Appendicesp. 119
Bulletin Board: Volume 5 Issue 2
Appendicesp. 260
Author guidelines: Volume 5 Issue 2
Appendicesp. 259
Acknowledgment: Volume 5 Issue 2
Appendicesp. 257
Indices: Volume 5 Issue 2
Appendicesp. 256
Glossary: Volume 5 Issue 2
Review Articlep. 177
Indirect and direct anticoagulants predominantly inhibiting factor Xa
Author(s): Job Harenberg
Review Articlep. 169
Venous thromboembolism: racial and ethnic influences
Author(s): Raj K Patel and Roopen Arya
Perspectivep. 151
Are isolated distal deep-vein thromboses clinically significant?
Author(s): AT Cohen, S Balaratnam and N Fassiadis
Review Articlep. 215
Association of hyperhomocysteinemia with osteoporosis: a systematic review
Author(s): Pooneh Salari, Bagher Larijani and Mohammad Abdollahi
Drug Evaluationp. 203
Rasagiline for the management of Parkinson��?s disease
Author(s): Khashayar Dashtipour, Jack J Chen and Mark F Lew
Editorialp. 195
Occupational therapy after stroke: a right not a privilege?
Author(s): Avril Drummond and Lynn Legg
Research Highlightsp. 139
Idraparinux for the prevention of thromboembolism in patients with atrial fibrillation
Author(s): Jaspal S Taggar, Gregory YH Lip, Aravinda Nanjundappa, Robert S Dieter, Sangeeta Mandapaka, Pranab Das and Shakeel Ahmad
Interviewp. 145
Dr Anna Falanga speaks to Charlotte Barker, Commissioning Editor
Author(s): Anna Falanga
Editorialp. 129
Where does patient self-management of oral anticoagulation fit within the current models of service provision?
Author(s): D A Fitzmaurice
Editorialp. 125
Warfarin pharmacogenetics: up close and personalized
Author(s): John F Carlquist and Jeffrey L Anderson
